Results 91 to 100 of about 376,320 (257)

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

open access: yesAdvanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang   +6 more
wiley   +1 more source

Polymyositis anti-SRP antibodies and pregnancy about 2 cases

open access: yesThe Pan African Medical Journal, 2016
Anti-SRP myopathy represents 4 to 6% of all the inflammatory myopathies. It has been described since the 80s and its influence on pregnancy and vice versa has been highlighted recently.
Cissé Ousmane   +11 more
doaj   +1 more source

Patient Characteristics of no corticosteroid and all corticosteroid users among IBD Veterans.

open access: yes, 2016
Patient Characteristics of no corticosteroid and all corticosteroid users among IBD Veterans.
Akbar K. Waljee (113901)   +10 more
core   +1 more source

Inhalable ROS‐Responsive Nanospray Activates PPAR‐γ to Restore Macrophage Mitochondrial Homeostasis and Attenuate Radiation‐Induced Lung Injury

open access: yesAdvanced Science, EarlyView.
A nebulized nanoassembly alleviates radiation‐induced lung injury by reprogramming macrophages through coordinated ROS scavenging, NAD+ replenishment, and PPAR‐γ activation. Redox balance, mitochondrial homeostasis, and immune regulation are restored, revealing a microenvironment‐centered strategy for localized radioprotection.
Mingquan Gao   +11 more
wiley   +1 more source

Corticosteroid-dependent chronic immune thrombocytopenic purpura in an 11-year-old child responsive to low-dose rituximab: a case report

open access: yesRussian Open Medical Journal
Immune thrombocytopenia (ITP) is the most common platelet disorder in children. The peak incidence is observed from 1 to 7 years of age. We report the case of an 11-year-old boy who was diagnosed with ITP four years before visiting our clinic following a
Zainab Omar, Khder Yousf
doaj   +1 more source

Escalation to corticosteroid-sparing therapy for Veterans who were continuous corticosteroid users (CS).

open access: yes, 2016
Escalation to corticosteroid-sparing therapy for Veterans who were continuous corticosteroid users (CS).
Akbar K. Waljee (113901)   +10 more
core   +1 more source

Local corticosteroid injection for carpal tunnel syndrome

open access: yes, 2020
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of corticosteroids injected in or around the carpal tunnel for the treatment of carpal tunnel syndrome (CTS), compared with placebo,
Chapman, Kristine M.   +5 more
core   +1 more source

Probiotic‐Derived Vesicles Rectally Delivered via Thermo‐Gelling Copolymer Promote Mucosal Healing and Reduce Inflammation in Ulcerative Colitis

open access: yesAdvanced Science, EarlyView.
A thermo‐responsive rectal delivery platform integrating probiotic‐derived extracellular vesicles within a hyaluronic acid‐based copolymer enables localized and sustained therapy for ulcerative colitis. The formulation effectively suppresses inflammation, promotes macrophage polarization toward a regenerative phenotype, restores epithelial barrier ...
Ayushi Mairal   +5 more
wiley   +1 more source

Corticosteroid hypersensitivity in allergic rhinitis [PDF]

open access: yes, 2016
Corticosteroid hypersensitivity in allergic rhinitis. Background: intranasal corticosteroid (IC) is the most effective treatment method in allergic rhinitis patients who are unresponsive to antihistamines.
Arslan, Hande   +3 more
core  

Membrane‐Active Peptide Protects Against Inflammation by Targeting NLRP3 Activation at the Trans‐Golgi Network

open access: yesAdvanced Science, EarlyView.
The membrane‐active peptide Pep19‐2.5 reduces harmful inflammation by blocking activation of the NLRP3 inflammasome at trans‐Golgi network membranes. By targeting key membrane interactions, Pep19‐2.5 suppresses inflammatory IL‐1β production and alleviates allergic airway inflammation in mice, leading to reduced immune cell infiltration and improved ...
Jonas Engelhardt   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy